Wall teichoic acid deficiency in Staphylococcus aureus confers selective resistance to mammalian group IIA phospholipase A(2) and human beta-defensin 3
about
Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implicationsStaphylococcus aureus Colonization of the Mouse Gastrointestinal Tract Is Modulated by Wall Teichoic Acid, Capsule, and Surface ProteinsRole of Net Charge on Catalytic Domain and Influence of Cell Wall Binding Domain on Bactericidal Activity, Specificity, and Host Range of Phage LysinsAntimicrobial Peptides Targeting Gram-Positive BacteriaDermcidin-derived peptides show a different mode of action than the cathelicidin LL-37 against Staphylococcus aureus.The zwitterionic cell wall teichoic acid of Staphylococcus aureus provokes skin abscesses in mice by a novel CD4+ T-cell-dependent mechanism.Conformation of the phosphate D-alanine zwitterion in bacterial teichoic acid from nuclear magnetic resonance spectroscopy.Nox2 modification of LDL is essential for optimal apolipoprotein B-mediated control of agr type III Staphylococcus aureus quorum-sensing.Role of wall teichoic acids in Staphylococcus aureus endophthalmitis.Antimicrobial GL13K peptide coatings killed and ruptured the wall of Streptococcus gordonii and prevented formation and growth of biofilmsApolipoprotein B48, the Structural Component of Chylomicrons, Is Sufficient to Antagonize Staphylococcus aureus Quorum-Sensing.Mechanisms of resistance to antimicrobial peptides in staphylococci.Equilibrium binding behavior of magnesium to wall teichoic acidImmune-activating properties of Panton-Valentine leukocidin improve the outcome in a model of methicillin-resistant Staphylococcus aureus pneumonia.Membrane disruption by antimicrobial fatty acids releases low-molecular-weight proteins from Staphylococcus aureus.Toward an understanding of the evolution of Staphylococcus aureus strain USA300 during colonization in community householdsWall teichoic acid protects Staphylococcus aureus from inhibition by Congo red and other dyes.Bacterial resistance mechanisms against host defense peptides.Molecular determinants of bacterial sensitivity and resistance to mammalian Group IIA phospholipase A2.TarO-specific inhibitors of wall teichoic acid biosynthesis restore β-lactam efficacy against methicillin-resistant staphylococci.Contributions of the σ(W) , σ(M) and σ(X) regulons to the lantibiotic resistome of Bacillus subtilis.Wall teichoic acid protects Staphylococcus aureus against antimicrobial fatty acids from human skin.High-affinity caspase-4 binding to LPS presented as high molecular mass aggregates or in outer membrane vesicles.Antibacterial and membrane-damaging activities of β-bungarotoxin B chain.Spectrum of antibacterial activity and mode of action of a novel tris-stilbene bacteriostatic compound.Streptococcal Lancefield polysaccharides are critical cell wall determinants for human Group IIA secreted phospholipase A2 to exert its bactericidal effects
P2860
Q24646677-5711F522-C50E-4160-92D4-63538F4F9005Q27318407-649CA084-20FC-47A6-9DD3-8A918C336BBBQ27671535-5510599A-CB4F-46BF-92D5-7AA216450973Q28077888-D0148C55-66E8-4E25-ACA0-B5B18D57B2CDQ30484849-B2364F0E-9119-4843-8E3B-5FE0A07B8421Q33719517-35228939-40C4-42B2-B0CD-7297672E9B29Q34338343-20B43B7A-BCC0-416A-A970-37126D9ACC78Q34608010-B1A94D31-99D8-4D00-96C9-B1557BF3DB36Q35027531-3CA6E92E-405E-4C83-AE64-AEB8FA6C71E6Q35395749-C9A674B1-650D-4094-8898-21456740DCD5Q35622488-49A2BC30-140C-4A66-8015-2F8B979035C9Q35963449-7E78B896-EAE4-49A0-8BF2-EA6492E79ECFQ36011380-48996A0D-57FB-4BB6-95CC-FE28E3B3BF80Q36211152-7C93DDA0-2B6A-45C7-8E6E-B3EB46B7DFDFQ36276367-A490A209-BA21-45C9-B80A-9898811BC4D6Q36525045-820C80F3-DE96-4AF7-BF4C-D378B03819E5Q36647027-B844E5C1-86F9-4FFA-ADFC-7800EF356B8FQ37874201-8FC33DFC-957A-414D-BBBB-D3480D759851Q38529191-4FB650FC-BE6F-4053-84D2-E5E029BD6C61Q40760998-9CD9E512-03D4-419B-BDFF-F479BC06710CQ41017751-C7E4A28C-06C8-4271-A2C0-0E13AAC3D4FDQ41363086-7ACE7C4B-F88B-43ED-A9F0-C590ACDDDE28Q51058627-1775AF8B-A834-4551-8F93-7852E89E240AQ54323992-5EFE6FF5-A4DB-4117-8DB1-00A62DAA4B55Q55024892-B2218404-95CE-43FF-9633-A9AB05AC3DE3Q57465697-E91BA75C-A945-4508-9241-98119ECD1313
P2860
Wall teichoic acid deficiency in Staphylococcus aureus confers selective resistance to mammalian group IIA phospholipase A(2) and human beta-defensin 3
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Wall teichoic acid deficiency ...... lian group IIA phospholipase A
@nl
Wall teichoic acid deficiency ...... A(2) and human beta-defensin 3
@en
type
label
Wall teichoic acid deficiency ...... lian group IIA phospholipase A
@nl
Wall teichoic acid deficiency ...... A(2) and human beta-defensin 3
@en
prefLabel
Wall teichoic acid deficiency ...... lian group IIA phospholipase A
@nl
Wall teichoic acid deficiency ...... A(2) and human beta-defensin 3
@en
P2860
P356
P1476
Wall teichoic acid deficiency ...... A(2) and human beta-defensin 3
@en
P2093
Andreas Peschel
Tomaz Koprivnjak
P2860
P304
P356
10.1128/IAI.01705-07
P407
P577
2008-03-17T00:00:00Z